|
2023
|
Invention
|
Compounds and compositions for immunotherapy.
The present invention relates to compounds for tar... |
|
2022
|
Invention
|
Pharmaceutical compositions.
The present disclosure relates to new crystal forms of chemical com... |
|
2021
|
Invention
|
Anti-cd20 combinations for treating tumors.
The present invention relates to therapeutic combina... |
|
|
Invention
|
Anti-egfr combinations for treating tumors. The present invention relates to therapeutic combinat... |
|
|
Invention
|
Cancer treatment with tlr agonist.
The present specification provides methods of monotherapy for... |
|
|
Invention
|
Cancer treatment with tlr agonist. The present specification provides methods of monotherapy for ... |
|
|
Invention
|
Anti pd-l1 conjugates for treating tumors.
The present invention relates to anti-PD-L/PD-1 Axis ... |
|
|
Invention
|
Anti-her2 combinations for treating tumors.
The present invention relates to therapeutic combina... |
|
|
Invention
|
2-amino-quinoline derivatives. Described herein are 2-amino-quinoline derivatives that are agonis... |
|
|
Invention
|
2-amino-quinoline derivatives.
Described herein are 2-amino-quinoline derivatives that are agoni... |
|
2020
|
Invention
|
Compounds and compositions for immunotherapy. The present invention relates to compounds for targ... |
|
|
Invention
|
Compounds and compositions for treating her2 positive tumors. The present invention relates to co... |
|
|
Invention
|
Immune modulatory compositions and methods for treating cancers.
The present disclosure relates ... |
|
|
Invention
|
Immune modulatory compositions and methods for treating cancers. The present disclosure relates t... |
|
|
Invention
|
Compounds for targeted immunotherapy.
Compounds for targeted immunotherapy, compositions compris... |
|
2019
|
Invention
|
Immune modulatory combinations and methods for treating cancers.
The presently disclosed embodim... |
|
|
Invention
|
Immune modulatory combinations and methods for treating cancers. The presently disclosed embodime... |
|
|
Invention
|
Imidazoquinoline compounds and uses thereof.
Provided herein are imidazoquinoline derivatives, o... |
|
|
Invention
|
Imidazoquinoline compounds and uses thereof. Provided herein are imidazoquinoline derivatives, or... |
|
2018
|
Invention
|
Combination therapy compositions and methods for treating cancers.
The present invention relates... |
|
|
Invention
|
Anti-pd-l1 combinations for treating tumors.
The present invention relates to therapeutic combin... |
|
|
Invention
|
Anti-pd-l1 combinations for treating tumors. The present invention relates to therapeutic combina... |
|
2017
|
Invention
|
Compounds for targeted immunotherapy. Compounds for targeted immunotherapy, compositions comprisi... |
|
|
Invention
|
Pharmaceutical compositions. The present disclosure relates to new crystal forms of chemical comp... |
|
|
Invention
|
Crystalline resiquimod monosulfate anhydrate and its preparation and uses. The present disclosure... |
|
|
Invention
|
Anti-cd20 combinations for treating tumors. The present invention relates to therapeutic combinat... |
|
|
Invention
|
Anti-her2 combinations for treating tumors. A combination which comprises an effective amount of ... |
|
2015
|
Invention
|
Anti pd-l1 conjugates for treating tumors. The present invention discloses anti-PD-L/PD-1 Axis an... |
|
|
Invention
|
Compounds and compositions for immunotherapy. Provided are compounds for targeted immunotherapy. ... |
|
|
Invention
|
Compounds and compositions for treating egfr expressing tumors. Provided are compounds for target... |
